Search - tctmd.com

Displaying 261 - 280 of 433

Sort: Relevancy | Date

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

L.A. McKeown

September 27, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

News Daily News

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Yael L. Maxwell

September 13, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Industry News

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

July 10, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Plavix and PPI

June 28, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

L.A. McKeown

June 07, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Industry News

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

May 22, 2013

News Industry News

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 21, 2013

News Daily News

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

Yael L. Maxwell

May 08, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

Advertisement

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Prior Cancer Diagnosis Increases Mortality Risk After Primary PCI for STEMI

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

Conversations in Cardiology: Plavix and PPI

SES Show Advantage Over ZES, PES for Diabetic Patients

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content